Skip to main content
Fig. 7 | BMC Medicine

Fig. 7

From: Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging

Fig. 7

Independent ELISA validation of elevated urinary proteins in a second validation cohort of Chinese BC patients. Dot plots depict the three urine proteins that were ELISA tested in a second validation cohort of Chinese ethnicity, comprised of BC patients (N = 91) and UC (N = 77), including 19 with kidney cancer, 4 with kidney cyst, 1 with kidney harmatoma, 50 with kidney stones, 1 with fibrous epithelial polyp, and 2 with kidney angiomyolipoma, as detailed in the supplementary figures/methods. Creatinine-normalized protein values are shown for each group (black dot = UC, black square = BC). The asterisks indicate the level of significance between the groups: **p < 0.01, ****p < 0.0001

Back to article page